Molecule Generation

13:20 PM - 13:45 PM

Use Case: Using AI to Deconvolute and Take Away the Complexity of Biology: Developing the Next Generation of Precision Oncology Therapeutics to Strike and Beat Cancer

Transformative treatment advances in oncology require a greater understanding of cancer as a complex disease and matching treatment to patient tumor biology. This use case will cover an example of a platform that leverages systems biology and pharmacology-based AI to develop a new wave of therapeutics and inform the rational design of combination trials matched to the right patient population.

Laurent Audoly, Ph.D, CEO, Founder, Parthenon Therapeutics
/* */